<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02504216</url>
  </required_header>
  <id_info>
    <org_study_id>17454</org_study_id>
    <secondary_id>2014-005569-58</secondary_id>
    <nct_id>NCT02504216</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities</brief_title>
  <acronym>VOYAGER PAD</acronym>
  <official_title>An International, Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Trial Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Thrombotic Vascular Events in Patients With Symptomatic Peripheral Artery Disease Undergoing Lower Extremity Revascularization Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Janssen Research &amp; Development, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Colorado Prevention Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of study was to test whether rivaroxaban added to standard of care treatment,&#xD;
      when compared to placebo, had the potential to reduce the incidence of the clinical events&#xD;
      related to the clots and complications of the heart and brain (CV death, MI, or stroke) or&#xD;
      the legs (acute limb ischemia or major amputation) in patients who had undergone recent&#xD;
      procedure(s) to improve the blood flow of their legs.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 18, 2015</start_date>
  <completion_date type="Actual">January 9, 2020</completion_date>
  <primary_completion_date type="Actual">November 27, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Efficacy Outcome: Number of Participants With Composite of Myocardial Infarction (MI), Ischemic Stroke, Cardiovascular Death, Acute Limb Ischemia (ALI) and Major Amputation Due to a Vascular Etiology</measure>
    <time_frame>For each participant, the first occurrence of the composite primary efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean time in follow-up survival time until ECOD that date was 1109.76 days.</time_frame>
    <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Safety Outcome: Number of Participants With TIMI (Thrombolysis in Myocardial Infarction) Major Bleeding</measure>
    <time_frame>For each participant, the first occurrence of the primary safety outcome after randomization up until 2 days after permanent stop of study drug (rivaroxaban or rivaroxaban placebo).</time_frame>
    <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Composite of MI, Ischemic Stroke, Coronary Heart Disease (CHD) Death, ALI, and Major Amputation of a Vascular Etiology</measure>
    <time_frame>For each participant, the first occurrence of the composite efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1108.79 days.</time_frame>
    <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With an Unplanned Index Limb Revascularization for Recurrent Limb Ischemia (Subsequent Index Leg Revascularization That Was Not Planned or Considered as Part of the Initial Treatment Plan at the Time of Randomization)</measure>
    <time_frame>For each participant, the first occurrence of the efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1062.48 days.</time_frame>
    <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Hospitalization for a Coronary or Peripheral Cause (Either Lower Limb) of a Thrombotic Nature</measure>
    <time_frame>For each participant, the first occurrence of the efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1154.04 days</time_frame>
    <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Composite of MI, Ischemic Stroke, All-cause Mortality (ACM), ALI, and Major Amputation of a Vascular Etiology</measure>
    <time_frame>For each participant, the first occurrence of the composite efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1085.13 days</time_frame>
    <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Composite of MI, All-cause Stroke, Cardiovascular (CV) Death, Acute Limb Ischemia (ALI), and Major Amputation of a Vascular Etiology</measure>
    <time_frame>For each participant, the first occurrence of the composite efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1108.29 days</time_frame>
    <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Mortality (All-cause)</measure>
    <time_frame>For each participant, the first occurrence of the outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1188.48 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Venous Thromboembolic (VTE) Events</measure>
    <time_frame>For each participant, the first occurrence of the outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1187.65 days</time_frame>
    <description>Venous thromboembolic events were reported by investigator only.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Safety Outcome: Number of Participants With ISTH (International Society on Thrombosis and Haemostasis) Major Bleeding</measure>
    <time_frame>For each participant, the first occurrence of the major bleeding events according to the ISTH classification after randomization up until 2 days after permanent stop of study drug (rivaroxaban or rivaroxaban placebo).</time_frame>
    <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Safety Outcome: Number of Participants With BARC (Bleeding Academic Research Consortium) Type 3b and Above Bleeding Events</measure>
    <time_frame>For each participant, the first occurrence of the type 3b and above bleeding events according to the BARC classification after randomization up until 2 days after permanent stop of study drug (rivaroxaban or rivaroxaban placebo)</time_frame>
    <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6564</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <arm_group>
    <arm_group_label>Rivaroxaban</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rivaroxaban 2.5 mg orally twice daily (5 mg cumulative daily dose)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Rivaroxaban-placebo orally twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rivaroxaban (Xarelto, BAY59-7939)</intervention_name>
    <description>2.5 mg, twice daily, orally, tablet</description>
    <arm_group_label>Rivaroxaban</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rivaroxaban-Placebo</intervention_name>
    <description>matching placebo, twice daily, orally, tablet</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥50&#xD;
&#xD;
          -  Documented moderate to severe symptomatic lower extremity atherosclerotic peripheral&#xD;
             artery disease&#xD;
&#xD;
          -  Technically successful peripheral revascularization distal to the external iliac&#xD;
             artery for symptomatic PAD (Peripheral artery disease) within the last 10 days prior&#xD;
             to randomization&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing revascularization for asymptomatic PAD or mild claudication&#xD;
             without functional limitation of the index leg.&#xD;
&#xD;
          -  Patients undergoing revascularization of the index leg to treat an asymptomatic or&#xD;
             minimally symptomatic restenosis of a bypass graft or target lesion restenosis.&#xD;
&#xD;
          -  Prior revascularization on the index leg within 10 days of the qualifying&#xD;
             revascularization.&#xD;
&#xD;
          -  Planned dual antiplatelet therapy (DAPT) use for the qualifying revascularization&#xD;
             procedure of clopidogrel in addition to Acetylic salicylic acid (ASA) for &gt;6 months&#xD;
             after the qualifying revascularization procedure; it is strongly recommended that any&#xD;
             course of clopidogrel is kept to the minimum necessary in accordance with local&#xD;
             standard of care and international practice guidelines (typically 30 days, or up to 60&#xD;
             days for some drug-coated products or devices) and is only allowed for up to 6 months&#xD;
             for complex procedures or devices in the investigator's opinion that require longer&#xD;
             use.&#xD;
&#xD;
          -  Planned use of any additional antiplatelet agent other than clopidogrel and ASA after&#xD;
             the qualifying revascularization procedure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Alexander City</city>
        <state>Alabama</state>
        <zip>35010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294-0012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Payne</city>
        <state>Alabama</state>
        <zip>35967</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801-4317</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Avondale</city>
        <state>Arizona</state>
        <zip>85388</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85340</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20422</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hudson</city>
        <state>Florida</state>
        <zip>34667</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34474</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Safety Harbor</city>
        <state>Florida</state>
        <zip>34695</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wellington</city>
        <state>Florida</state>
        <zip>33449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46845</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Merrillville</city>
        <state>Indiana</state>
        <zip>46410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alexandria</city>
        <state>Louisiana</state>
        <zip>71301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Covington</city>
        <state>Louisiana</state>
        <zip>70433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lewiston</city>
        <state>Maine</state>
        <zip>04240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201-1595</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Clinton</city>
        <state>Maryland</state>
        <zip>20735</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bay City</city>
        <state>Michigan</state>
        <zip>48708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dearborn</city>
        <state>Michigan</state>
        <zip>48126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Midland</city>
        <state>Michigan</state>
        <zip>48670</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Muskegon</city>
        <state>Michigan</state>
        <zip>49444</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wyoming</city>
        <state>Michigan</state>
        <zip>49519</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Flemington</city>
        <state>New Jersey</state>
        <zip>08822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Linden</city>
        <state>New Jersey</state>
        <zip>07036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saratoga Springs</city>
        <state>New York</state>
        <zip>12866</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27517</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Minot</city>
        <state>North Dakota</state>
        <zip>58701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Springfield</city>
        <state>Ohio</state>
        <zip>45505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hillsboro</city>
        <state>Oregon</state>
        <zip>97123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29657</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37934</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216-7167</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edinburg</city>
        <state>Texas</state>
        <zip>78539</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Humble</city>
        <state>Texas</state>
        <zip>77338</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Huntsville</city>
        <state>Texas</state>
        <zip>77340</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kingwood</city>
        <state>Texas</state>
        <zip>77339</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Victoria</city>
        <state>Texas</state>
        <zip>77901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manitowoc</city>
        <state>Wisconsin</state>
        <zip>54220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bahia Blanca</city>
        <state>Buenos Aires</state>
        <zip>B8001HXM</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudadela</city>
        <state>Buenos Aires</state>
        <zip>1702</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Coronel Suarez</city>
        <state>Buenos Aires</state>
        <zip>B7540GHD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Junín</city>
        <state>Buenos Aires</state>
        <zip>B6000BHA</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>1900</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>B1900ASM</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mar del Plata</city>
        <state>Buenos Aires</state>
        <zip>7600</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Isidro</city>
        <state>Buenos Aires</state>
        <zip>B1642DCD</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Martín</city>
        <state>Buenos Aires</state>
        <zip>1650</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buenos Aires</city>
        <state>Ciudad Auton. De Buenos Aires</state>
        <zip>1078</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buenos Aires</city>
        <state>Ciudad Auton. De Buenos Aires</state>
        <zip>C1119ACN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buenos Aires</city>
        <state>Ciudad Auton. De Buenos Aires</state>
        <zip>C1280AEB</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buenos Aires</city>
        <state>Ciudad Auton. De Buenos Aires</state>
        <zip>C1428ART</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Rosa</city>
        <state>La Pampa</state>
        <zip>6300</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000PBJ</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <zip>S2000QID</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudad Auton. de Buenos Aires</city>
        <zip>C1181ACL</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corrientes</city>
        <zip>3400</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Córdoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Córdoba</city>
        <zip>X5000AAX</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Córdoba</city>
        <zip>X5006IKK</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Fe</city>
        <zip>S3000FWO</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Klagenfurt</city>
        <state>Kärnten</state>
        <zip>9020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Graz</city>
        <state>Steiermark</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Innsbruck</city>
        <state>Tirol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Feldkirch</city>
        <state>Vorarlberg</state>
        <zip>6807</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Linz</city>
        <zip>4021</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wien</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wien</city>
        <zip>1160</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wien</city>
        <zip>1170</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bruxelles - Brussel</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bruxelles - Brussel</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bruxelles - Brussel</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kortrijk</city>
        <zip>8500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fortaleza</city>
        <state>Ceará</state>
        <zip>60430 370</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30110-090</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30130-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30140-062</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30140-073</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Uberlândia</city>
        <state>Minas Gerais</state>
        <zip>38411-186</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Curitiba</city>
        <state>Parana</state>
        <zip>80230-130</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Canoas</city>
        <state>Rio Grande Do Sul</state>
        <zip>92200-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Passo Fundo</city>
        <state>Rio Grande Do Sul</state>
        <zip>99010-080</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <zip>90619900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <state>Sao Paulo</state>
        <zip>30110-130</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Campinas</city>
        <state>Sao Paulo</state>
        <zip>13060-080</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santo André</city>
        <state>Sao Paulo</state>
        <zip>09030-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>São Bernardo do Campo</city>
        <state>Sao Paulo</state>
        <zip>09715-090</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>São José do Rio Preto</city>
        <state>Sao Paulo</state>
        <zip>15090</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>São Paulo</city>
        <state>Sao Paulo</state>
        <zip>01323-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tatui</city>
        <state>Sao Paulo</state>
        <zip>18270-170</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rio de Janeiro</city>
        <zip>20551-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burgas</city>
        <zip>8000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Panagyurishte</city>
        <zip>4500</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Plovdiv</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ruse</city>
        <zip>7002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ruse</city>
        <zip>7013</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Samokov</city>
        <zip>2000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sofia</city>
        <zip>1309</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stara Zagora</city>
        <zip>6000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Varna</city>
        <zip>9010</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Yambol</city>
        <zip>8600</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1C 2H6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>ON N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicoutimi</city>
        <state>Quebec</state>
        <zip>G7H 5H6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gatineau</city>
        <state>Quebec</state>
        <zip>J8Y 6S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Jerome</city>
        <state>Quebec</state>
        <zip>J7Z 5T3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal, Quebec</city>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Quebec</city>
        <zip>G1L 3L5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vancouver</city>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350025</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zhangzhou</city>
        <state>Fujian</state>
        <zip>363000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zhanjiang</city>
        <state>Guangdong</state>
        <zip>524001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zhongshan</city>
        <state>Guangdong</state>
        <zip>528403</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <zip>570311</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430014</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Changzhou</city>
        <state>Jiangsu</state>
        <zip>213003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <zip>266003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>030001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taizhou</city>
        <state>Zhejiang</state>
        <zip>317000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beijing</city>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beijing</city>
        <zip>100083</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beijing</city>
        <zip>100144</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beijing</city>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shanghai</city>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shanghai</city>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tianjin</city>
        <zip>300000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brno</city>
        <zip>656 91</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hodonin</city>
        <zip>69501</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hradec kralove</city>
        <zip>500 05</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kladno</city>
        <zip>27259</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liberec</city>
        <zip>460 63</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Olomouc</city>
        <zip>775 20</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Plzen</city>
        <zip>30599</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 10</city>
        <zip>10100</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 2</city>
        <zip>12808</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 5</city>
        <zip>150 06</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 5</city>
        <zip>15006</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Prostejov</city>
        <zip>798 11</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vratimov</city>
        <zip>73932</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kolding</city>
        <zip>6000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>København Ø</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Odense C</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Viborg</city>
        <zip>8800</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tallin</city>
        <zip>11312</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tartu</city>
        <zip>50406</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bordeaux</city>
        <zip>33075</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Caen Cedex</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Castelnau Le Lez</city>
        <zip>34170</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Le Coudray</city>
        <zip>28630</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montpellier Cedex</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nice</city>
        <zip>06280</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris Cedex 15</city>
        <zip>75908</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris</city>
        <zip>75634</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>POITIERS cedex</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rennes Cedex</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toulouse</city>
        <zip>31300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toulouse</city>
        <zip>31403</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bad Friedrichshall</city>
        <state>Baden-Württemberg</state>
        <zip>74177</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bad Krozingen</city>
        <state>Baden-Württemberg</state>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Freudenstadt</city>
        <state>Baden-Württemberg</state>
        <zip>72250</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Karlsbad</city>
        <state>Baden-Württemberg</state>
        <zip>76307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Karlsruhe</city>
        <state>Baden-Württemberg</state>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ulm</city>
        <state>Baden-Württemberg</state>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Erlangen</city>
        <state>Bayern</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Immenstadt</city>
        <state>Bayern</state>
        <zip>87509</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80331</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Regensburg</city>
        <state>Bayern</state>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rosenheim</city>
        <state>Bayern</state>
        <zip>83022</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bad Nauheim</city>
        <state>Hessen</state>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Darmstadt</city>
        <state>Hessen</state>
        <zip>64276</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>65929</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arnsberg</city>
        <state>Nordrhein-Westfalen</state>
        <zip>59759</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bielefeld</city>
        <state>Nordrhein-Westfalen</state>
        <zip>33604</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Düsseldorf</city>
        <state>Nordrhein-Westfalen</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Krefeld</city>
        <state>Nordrhein-Westfalen</state>
        <zip>47805</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Köln</city>
        <state>Nordrhein-Westfalen</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Münster</city>
        <state>Nordrhein-Westfalen</state>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wesel</city>
        <state>Nordrhein-Westfalen</state>
        <zip>46483</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaiserslautern</city>
        <state>Rheinland-Pfalz</state>
        <zip>67657</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mainz</city>
        <state>Rheinland-Pfalz</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Magdeburg</city>
        <state>Sachsen-Anhalt</state>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lübeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jena</city>
        <state>Thüringen</state>
        <zip>07740</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sonneberg</city>
        <state>Thüringen</state>
        <zip>96515</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Berlin</city>
        <zip>10713</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Berlin</city>
        <zip>10787</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bremen</city>
        <zip>28277</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dresden</city>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Budapest</city>
        <zip>1085</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Budapest</city>
        <zip>1106</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Budapest</city>
        <zip>1115</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gyor</city>
        <zip>9023</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaposvar</city>
        <zip>7400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kistarcsa</city>
        <zip>2143</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miskolc</city>
        <zip>3526</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nyiregyhaza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pecs</city>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szekesfehervar</city>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szombathely</city>
        <zip>9700</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Potenza</city>
        <state>Basilicata</state>
        <zip>85100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Avellino</city>
        <state>Campania</state>
        <zip>83100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Napoli</city>
        <state>Campania</state>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bologna</city>
        <state>Emilia-Romagna</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ravenna</city>
        <state>Emilia-Romagna</state>
        <zip>48033</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Reggio Emilia</city>
        <state>Emilia-Romagna</state>
        <zip>42100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roma</city>
        <state>Lazio</state>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Milano</city>
        <state>Lombardia</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Varese</city>
        <state>Lombardia</state>
        <zip>21100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Macerata</city>
        <state>Marche</state>
        <zip>62100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Torino</city>
        <state>Piemonte</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lecce</city>
        <state>Puglia</state>
        <zip>73100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palermo</city>
        <state>Sicilia</state>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ragusa</city>
        <state>Sicilia</state>
        <zip>97100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Firenze</city>
        <state>Toscana</state>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Perugia</city>
        <state>Umbria</state>
        <zip>06132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nagakute</city>
        <state>Aichi</state>
        <zip>480-1195</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Matsuyama</city>
        <state>Ehime</state>
        <zip>790-8524</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kitakyushu</city>
        <state>Fukuoka</state>
        <zip>802-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kitakyushu</city>
        <state>Fukuoka</state>
        <zip>805-0050</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kurume</city>
        <state>Fukuoka</state>
        <zip>830-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shibukawa</city>
        <state>Gunma</state>
        <zip>377-0061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hatsukaichi</city>
        <state>Hiroshima</state>
        <zip>738-8503</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Asahikwa</city>
        <state>Hokkaido</state>
        <zip>078-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-0031</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>064-8622</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tomakomai</city>
        <state>Hokkaido</state>
        <zip>053-8506</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Amagasaki</city>
        <state>Hyogo</state>
        <zip>660-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Himeji</city>
        <state>Hyogo</state>
        <zip>670-0981</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Himeji</city>
        <state>Hyogo</state>
        <zip>671-1227</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <zip>650-0047</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <zip>651-0053</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Takarazuka</city>
        <state>Hyogo</state>
        <zip>665-0873</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Morioka</city>
        <state>Iwate</state>
        <zip>020-0066</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Takamatsu</city>
        <state>Kagawa</state>
        <zip>760-8557</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kawasaki</city>
        <state>Kanagawa</state>
        <zip>215-0026</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sagamihara</city>
        <state>Kanagawa</state>
        <zip>252-5188</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Matsusaka</city>
        <state>Mie</state>
        <zip>515-8566</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Matsumoto</city>
        <state>Nagano</state>
        <zip>390-8621</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kashihara</city>
        <state>Nara</state>
        <zip>634-8522</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beppu</city>
        <state>Oita</state>
        <zip>874-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Habikino</city>
        <state>Osaka</state>
        <zip>583-0872</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kawagoe</city>
        <state>Saitama</state>
        <zip>350-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Omihachiman</city>
        <state>Shiga</state>
        <zip>523-0082</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hamada</city>
        <state>Shimane</state>
        <zip>697-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-8519</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fuchu</city>
        <state>Tokyo</state>
        <zip>183-0003</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Itabashi-ku</city>
        <state>Tokyo</state>
        <zip>173-0015</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Itabashi-ku</city>
        <state>Tokyo</state>
        <zip>173-8610</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Meguro-ku</city>
        <state>Tokyo</state>
        <zip>152-8902</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Minato-ku</city>
        <state>Tokyo</state>
        <zip>108-8329</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Minato</city>
        <state>Tokyo</state>
        <zip>108-0073</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Suginami-ku</city>
        <state>Tokyo</state>
        <zip>166-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gifu</city>
        <zip>500-8717</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kagoshima</city>
        <zip>890-8760</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kumamoto</city>
        <zip>860-0008</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kyoto</city>
        <zip>604-8401</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kyoto</city>
        <zip>615-8256</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miyazaki</city>
        <zip>880-2102</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Osaka</city>
        <zip>530-0012</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Osaka</city>
        <zip>530-8480</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Osaka</city>
        <zip>558-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saitama</city>
        <zip>336-8522</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shizuoka</city>
        <zip>420-8630</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggido</state>
        <zip>10326</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggido</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Incheon</city>
        <state>Incheon Gwang''yeogsi</state>
        <zip>21565</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Busan</city>
        <zip>49201</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daegu</city>
        <zip>42472</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daegu</city>
        <zip>700-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daejeon</city>
        <zip>301-723</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jung-gu Daejeon</city>
        <zip>35015</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <zip>05368</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <zip>152-703</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daugavpils</city>
        <zip>LV-5417</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liepaja</city>
        <zip>LV-3414</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Riga</city>
        <zip>1038</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Riga</city>
        <zip>LV-1002</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaunas</city>
        <zip>45130</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaunas</city>
        <zip>LT-50009</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Panevezys</city>
        <zip>35144</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vilnius</city>
        <zip>LT-08661</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vilnius</city>
        <zip>LT-10207</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Den Bosch</city>
        <zip>5223 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Eindhoven</city>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Enschede</city>
        <zip>7611 JH</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Heerlen</city>
        <zip>6419 PC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Veldhoven</city>
        <zip>5504 DB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zwolle</city>
        <zip>8025 AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bialystok</city>
        <zip>15_111</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-094</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gdynia</city>
        <zip>81-338</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Katowice</city>
        <zip>40-040</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lodz</city>
        <zip>94-048</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lublin</city>
        <zip>20-044</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lublin</city>
        <zip>20-718</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Poznan</city>
        <zip>61-848</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Szczecin</city>
        <zip>70-111</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa</city>
        <zip>01-211</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa</city>
        <zip>01-868</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wroclaw</city>
        <zip>50-981</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Almada</city>
        <state>Setúbal</state>
        <zip>2805-267</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lisboa</city>
        <zip>1169-1024</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ponta Delgada</city>
        <zip>9500-370</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Porto</city>
        <zip>4099-001</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Porto</city>
        <zip>4200-319</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vila Nova de Gaia</city>
        <zip>4434-502</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pitesti</city>
        <state>Arges</state>
        <zip>110084</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bucharest</city>
        <zip>010192</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bucharest</city>
        <zip>011461</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bucharest</city>
        <zip>022322</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cluj Napoca</city>
        <zip>400001</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Iasi</city>
        <zip>700732</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oradea</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Targu Mures</city>
        <zip>540124</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Timisoara</city>
        <zip>300736</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kemerovo</city>
        <zip>650002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moscow</city>
        <zip>105077</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moscow</city>
        <zip>115682</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moscow</city>
        <zip>117997</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moscow</city>
        <zip>129327</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nizhny Novgorod</city>
        <zip>603155</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Novosibirsk</city>
        <zip>630087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rostov-on-Don</city>
        <zip>344022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ryazan</city>
        <zip>390026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint-Petersburg</city>
        <zip>197374</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Petersburg</city>
        <zip>191015</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Petersburg</city>
        <zip>194291</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Petersburg</city>
        <zip>194354</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Petersburg</city>
        <zip>195271</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tomsk</city>
        <zip>634012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tver</city>
        <zip>170036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Voronezh</city>
        <zip>394066</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belgrade</city>
        <zip>11040</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belgrade</city>
        <zip>11080</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beograd</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nis</city>
        <zip>18000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bardejov</city>
        <zip>085 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bratislava 37</city>
        <zip>833 48</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bratislava</city>
        <zip>83348</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bratislava</city>
        <zip>851 07</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dunajska Streda</city>
        <zip>92901</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kosice</city>
        <zip>04001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nitra</city>
        <zip>949 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nove Zamky</city>
        <zip>940 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Trnava</city>
        <zip>91701</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zilina</city>
        <zip>01001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cádiz</city>
        <state>Andalucía</state>
        <zip>11009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>L'Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>A Coruña</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ciudad Real</city>
        <zip>13005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Granada</city>
        <zip>18012</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pamplona</city>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tarragona</city>
        <zip>43005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Göteborg</city>
        <zip>413 46</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Linköping</city>
        <zip>582 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Malmö</city>
        <zip>205 02</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Solna</city>
        <zip>171 76</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Växjö</city>
        <zip>351 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Basel</city>
        <state>Basel-Stadt</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chur</city>
        <state>Graubünden</state>
        <zip>7000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Gallen</city>
        <state>Sankt Gallen</state>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baden</city>
        <zip>5404</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fribourg</city>
        <zip>1700</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Genève</city>
        <zip>1205</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Luzern</city>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hsinchu City</city>
        <zip>300</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaohsiung</city>
        <zip>813</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaohsiung</city>
        <zip>82445</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tainan</city>
        <zip>704</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taipei</city>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taipei</city>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Taoyuan</city>
        <zip>333423</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Songkla</city>
        <zip>90110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dnipro</city>
        <zip>49000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76014</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kharkiv</city>
        <zip>61018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kiev</city>
        <zip>3680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kyiv</city>
        <zip>1601</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lviv</city>
        <zip>79010</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vinnytsia</city>
        <zip>21018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zaporizhzhya</city>
        <zip>69600</zip>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Carlisle</city>
        <state>Cumbria</state>
        <zip>CA2 7HY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hull</city>
        <state>Humberside</state>
        <zip>HU3 2JZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Harrow</city>
        <state>London</state>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Doncaster</city>
        <state>South Yorkshire</state>
        <zip>DN2 5LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Newcastle Upon Tyne</city>
        <state>Tyne And Wear</state>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leeds</city>
        <state>West Yorkshire</state>
        <zip>LS1 3EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Worcester</city>
        <state>Worcestershire</state>
        <zip>WR5 1DD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cambridge</city>
        <zip>CB3 OLB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cheltenham</city>
        <zip>GL53 7AN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>London</city>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>London</city>
        <zip>W6 8RF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manchester</city>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sheffield</city>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>China</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>July 20, 2015</study_first_submitted>
  <study_first_submitted_qc>July 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2015</study_first_posted>
  <results_first_submitted>November 9, 2020</results_first_submitted>
  <results_first_submitted_qc>December 7, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 8, 2020</results_first_posted>
  <last_update_submitted>December 7, 2020</last_update_submitted>
  <last_update_submitted_qc>December 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rivaroxaban</keyword>
  <keyword>Xarelto</keyword>
  <keyword>Aspirin</keyword>
  <keyword>Acetylic salicylic acid</keyword>
  <keyword>Anticoagulant</keyword>
  <keyword>Peripheral artery disease</keyword>
  <keyword>Peripheral arterial disease</keyword>
  <keyword>Revascularization</keyword>
  <keyword>Acute limb ischemia</keyword>
  <keyword>Amputation</keyword>
  <keyword>Cardiovascular events</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rivaroxaban</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 24, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT02504216/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 21, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT02504216/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study was conducted at 548 centers which screened participants (534 sites randomized participants) worldwide between 18 Aug 2015 (first patient's first visit) and 27 Nov 2019 (last patient's last visit).</recruitment_details>
      <pre_assignment_details>A total of 6772 participants were screened, of which 6564 were randomly assigned to either of the two treatment arms.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
          <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
        </group>
        <group group_id="P2">
          <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
          <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3286"/>
                <participants group_id="P2" count="3278"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received Treatment</title>
              <participants_list>
                <participants group_id="P1" count="3256"/>
                <participants group_id="P2" count="3248"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3275"/>
                <participants group_id="P2" count="3263"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
          <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
        </group>
        <group group_id="B2">
          <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
          <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3286"/>
            <count group_id="B2" value="3278"/>
            <count group_id="B3" value="6564"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.0" lower_limit="49" upper_limit="93"/>
                    <measurement group_id="B2" value="67.0" lower_limit="50" upper_limit="95"/>
                    <measurement group_id="B3" value="67" lower_limit="49" upper_limit="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="847"/>
                    <measurement group_id="B2" value="857"/>
                    <measurement group_id="B3" value="1704"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2439"/>
                    <measurement group_id="B2" value="2421"/>
                    <measurement group_id="B3" value="4860"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="484"/>
                    <measurement group_id="B2" value="482"/>
                    <measurement group_id="B3" value="966"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                    <measurement group_id="B2" value="71"/>
                    <measurement group_id="B3" value="155"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2647"/>
                    <measurement group_id="B2" value="2656"/>
                    <measurement group_id="B3" value="5303"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Efficacy Outcome: Number of Participants With Composite of Myocardial Infarction (MI), Ischemic Stroke, Cardiovascular Death, Acute Limb Ischemia (ALI) and Major Amputation Due to a Vascular Etiology</title>
        <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
        <time_frame>For each participant, the first occurrence of the composite primary efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean time in follow-up survival time until ECOD that date was 1109.76 days.</time_frame>
        <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Efficacy Outcome: Number of Participants With Composite of Myocardial Infarction (MI), Ischemic Stroke, Cardiovascular Death, Acute Limb Ischemia (ALI) and Major Amputation Due to a Vascular Etiology</title>
          <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
          <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3286"/>
                <count group_id="O2" value="3278"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="508"/>
                    <measurement group_id="O2" value="584"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>IxRS: Interactive web/voice response system</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.0043</p_value>
            <method>Log Rank</method>
            <method_desc>P-value (1-sided) is based on the log rank test stratified by type of procedure and clopidogrel use per IxRS assignment with treatment as a factor.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.76</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Primary Safety Outcome: Number of Participants With TIMI (Thrombolysis in Myocardial Infarction) Major Bleeding</title>
        <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
        <time_frame>For each participant, the first occurrence of the primary safety outcome after randomization up until 2 days after permanent stop of study drug (rivaroxaban or rivaroxaban placebo).</time_frame>
        <population>Safety analysis set (SAF Set): Comprised all treated participants, i.e. randomized participants who received at least one dose of study drug (rivaroxaban or rivaroxaban placebo).</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Safety Outcome: Number of Participants With TIMI (Thrombolysis in Myocardial Infarction) Major Bleeding</title>
          <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
          <population>Safety analysis set (SAF Set): Comprised all treated participants, i.e. randomized participants who received at least one dose of study drug (rivaroxaban or rivaroxaban placebo).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3256"/>
                <count group_id="O2" value="3248"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>=0.0695</p_value>
            <method>Log Rank</method>
            <method_desc>P-value (2-sided) is based on the log rank test stratified by type of procedure and clopidogrel use per IxRS assignment with treatment as a factor.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.43</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.97</ci_lower_limit>
            <ci_upper_limit>2.10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Composite of MI, Ischemic Stroke, Coronary Heart Disease (CHD) Death, ALI, and Major Amputation of a Vascular Etiology</title>
        <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
        <time_frame>For each participant, the first occurrence of the composite efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1108.79 days.</time_frame>
        <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Composite of MI, Ischemic Stroke, Coronary Heart Disease (CHD) Death, ALI, and Major Amputation of a Vascular Etiology</title>
          <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
          <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3286"/>
                <count group_id="O2" value="3278"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="433"/>
                    <measurement group_id="O2" value="528"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.0004</p_value>
            <p_value_desc>P-value (1-sided) is based on the log rank test stratified by type of procedure and clopidogrel use per IxRS assignment with treatment as a factor.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>0.91</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With an Unplanned Index Limb Revascularization for Recurrent Limb Ischemia (Subsequent Index Leg Revascularization That Was Not Planned or Considered as Part of the Initial Treatment Plan at the Time of Randomization)</title>
        <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
        <time_frame>For each participant, the first occurrence of the efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1062.48 days.</time_frame>
        <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With an Unplanned Index Limb Revascularization for Recurrent Limb Ischemia (Subsequent Index Leg Revascularization That Was Not Planned or Considered as Part of the Initial Treatment Plan at the Time of Randomization)</title>
          <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
          <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3286"/>
                <count group_id="O2" value="3278"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="584"/>
                    <measurement group_id="O2" value="655"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.0140</p_value>
            <p_value_desc>P-value (1-sided) is based on the log rank test stratified by type of procedure and clopidogrel use per IxRS assignment with treatment as a factor.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.88</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.79</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Hospitalization for a Coronary or Peripheral Cause (Either Lower Limb) of a Thrombotic Nature</title>
        <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
        <time_frame>For each participant, the first occurrence of the efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1154.04 days</time_frame>
        <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Hospitalization for a Coronary or Peripheral Cause (Either Lower Limb) of a Thrombotic Nature</title>
          <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
          <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3286"/>
                <count group_id="O2" value="3278"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="262"/>
                    <measurement group_id="O2" value="356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>P-value (1-sided) is based on the log rank test stratified by type of procedure and clopidogrel use per IxRS assignment with treatment as a factor.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>0.85</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Composite of MI, Ischemic Stroke, All-cause Mortality (ACM), ALI, and Major Amputation of a Vascular Etiology</title>
        <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
        <time_frame>For each participant, the first occurrence of the composite efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1085.13 days</time_frame>
        <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Composite of MI, Ischemic Stroke, All-cause Mortality (ACM), ALI, and Major Amputation of a Vascular Etiology</title>
          <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
          <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3286"/>
                <count group_id="O2" value="3278"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="614"/>
                    <measurement group_id="O2" value="679"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.0145</p_value>
            <p_value_desc>P-value (1-sided) is based on the log rank test stratified by type of procedure and clopidogrel use per IxRS assignment with treatment as a factor.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.89</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.79</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Composite of MI, All-cause Stroke, Cardiovascular (CV) Death, Acute Limb Ischemia (ALI), and Major Amputation of a Vascular Etiology</title>
        <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
        <time_frame>For each participant, the first occurrence of the composite efficacy outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1108.29 days</time_frame>
        <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Composite of MI, All-cause Stroke, Cardiovascular (CV) Death, Acute Limb Ischemia (ALI), and Major Amputation of a Vascular Etiology</title>
          <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
          <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3286"/>
                <count group_id="O2" value="3278"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="514"/>
                    <measurement group_id="O2" value="588"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.0051</p_value>
            <p_value_desc>P-value (1-sided) is based on the log rank test stratified by type of procedure and clopidogrel use per IxRS assignment with treatment as a factor.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.86</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.76</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Mortality (All-cause)</title>
        <time_frame>For each participant, the first occurrence of the outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1188.48 days</time_frame>
        <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Mortality (All-cause)</title>
          <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3286"/>
                <count group_id="O2" value="3278"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="321"/>
                    <measurement group_id="O2" value="297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.8322</p_value>
            <p_value_desc>P-value (1-sided) is based on the log rank test stratified by type of procedure and clopidogrel use per IxRS assignment with treatment as a factor.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.92</ci_lower_limit>
            <ci_upper_limit>1.27</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Venous Thromboembolic (VTE) Events</title>
        <description>Venous thromboembolic events were reported by investigator only.</description>
        <time_frame>For each participant, the first occurrence of the outcome after randomization up until the efficacy cut-off date (08-Sep-2019) was considered. The mean survival time until ECOD was 1187.65 days</time_frame>
        <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Venous Thromboembolic (VTE) Events</title>
          <description>Venous thromboembolic events were reported by investigator only.</description>
          <population>Intention-to-treat analysis set (ITT Set): Comprised all randomized participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3286"/>
                <count group_id="O2" value="3278"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.0235</p_value>
            <p_value_desc>P-value (1-sided) is based on the log rank test stratified by type of procedure and clopidogrel use per IxRS assignment with treatment as a factor.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.61</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.37</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Secondary Safety Outcome: Number of Participants With ISTH (International Society on Thrombosis and Haemostasis) Major Bleeding</title>
        <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
        <time_frame>For each participant, the first occurrence of the major bleeding events according to the ISTH classification after randomization up until 2 days after permanent stop of study drug (rivaroxaban or rivaroxaban placebo).</time_frame>
        <population>Safety analysis set (SAF Set): Comprised all treated participants, i.e. randomized participants who received at least one dose of study drug (rivaroxaban or rivaroxaban placebo).</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Secondary Safety Outcome: Number of Participants With ISTH (International Society on Thrombosis and Haemostasis) Major Bleeding</title>
          <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered.</description>
          <population>Safety analysis set (SAF Set): Comprised all treated participants, i.e. randomized participants who received at least one dose of study drug (rivaroxaban or rivaroxaban placebo).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3256"/>
                <count group_id="O2" value="3248"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140"/>
                    <measurement group_id="O2" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>=0.0068</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.42</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.10</ci_lower_limit>
            <ci_upper_limit>1.84</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Secondary Safety Outcome: Number of Participants With BARC (Bleeding Academic Research Consortium) Type 3b and Above Bleeding Events</title>
        <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered</description>
        <time_frame>For each participant, the first occurrence of the type 3b and above bleeding events according to the BARC classification after randomization up until 2 days after permanent stop of study drug (rivaroxaban or rivaroxaban placebo)</time_frame>
        <population>Safety analysis set (SAF Set): Comprised all treated participants, i.e. randomized participants who received at least one dose of study drug (rivaroxaban or rivaroxaban placebo).</population>
        <group_list>
          <group group_id="O1">
            <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
          </group>
          <group group_id="O2">
            <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
            <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
          </group>
        </group_list>
        <measure>
          <title>Secondary Safety Outcome: Number of Participants With BARC (Bleeding Academic Research Consortium) Type 3b and Above Bleeding Events</title>
          <description>Only the first occurrence of the outcome event under analysis within the data scope from a participant is considered</description>
          <population>Safety analysis set (SAF Set): Comprised all treated participants, i.e. randomized participants who received at least one dose of study drug (rivaroxaban or rivaroxaban placebo).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3256"/>
                <count group_id="O2" value="3248"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                    <measurement group_id="O2" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>=0.0979</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.29</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.95</ci_lower_limit>
            <ci_upper_limit>1.76</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From randomization until 2 days following permanent discontinuation of the study drug</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Rivaroxaban 2.5 mg Bid + Aspirin 100 mg od</title>
          <description>Participants were treated with Rivaroxaban 2.5 mg twice-daily (bid) and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily (od)</description>
        </group>
        <group group_id="E2">
          <title>Rivaroxaban Placebo Bid + Aspirin 100 mg od</title>
          <description>Participants were treated with Rivaroxaban-placebo twice-daily and aspirin (ASA: Acetylsalicylic Acid) 100 mg once-daily</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (22.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="327" subjects_at_risk="3256"/>
                <counts group_id="E2" subjects_affected="304" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="948" subjects_at_risk="3256"/>
                <counts group_id="E2" subjects_affected="927" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="16" subjects_affected="14" subjects_at_risk="3256"/>
                <counts group_id="E2" events="13" subjects_affected="10" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Normocytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Thrombocytosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Nephrogenic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Blood loss anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="3256"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="16" subjects_affected="14" subjects_at_risk="3256"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="3256"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="18" subjects_affected="15" subjects_at_risk="3256"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cyanosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pericardial haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sinus arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Supraventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Stress cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Congenital bladder neck obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Adenomatous polyposis coli</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Iridocyclitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Myopia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Macular hole</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Detachment of macular retinal pigment epithelium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vitreoretinal traction syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Macular detachment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Abdominal mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Anal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dental alveolar anomaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diaphragmatic hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gallstone ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intestinal angina</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intestinal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pancreatitis necrotising</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peptic ulcer perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Periodontal disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Small intestinal perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Tooth loss</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Umbilical hernia, obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pancreatic mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric antral vascular ectasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oedematous pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Alcoholic pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Large intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Enterovesical fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pancreatic duct stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Abdominal incarcerated hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Obstructive pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Crepitations</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Granuloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Puncture site haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Organ failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Drug intolerance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular stent thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Stent-graft endoleak</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular stent occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular stent stenosis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular device occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cholangitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cirrhosis alcoholic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hepatorenal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Steatohepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Primary biliary cholangitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arteriosclerotic gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Blister infected</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Carbuncle</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="3256"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cellulitis gangrenous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Eczema infected</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Escherichia sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Fournier's gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Fungal cystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Fungal skin infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="3256"/>
                <counts group_id="E2" events="22" subjects_affected="20" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="3256"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lymphangitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ophthalmic herpes zoster</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Osteomyelitis chronic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Perinephric abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="49" subjects_affected="40" subjects_at_risk="3256"/>
                <counts group_id="E2" events="50" subjects_affected="45" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="28" subjects_affected="27" subjects_at_risk="3256"/>
                <counts group_id="E2" events="26" subjects_affected="25" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="3256"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="17" subjects_affected="13" subjects_at_risk="3256"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="19" subjects_affected="17" subjects_at_risk="3256"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Scrotal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Groin infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lymph gland infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Periumbilical abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Burn infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Perineal abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Graft infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Infected lymphocele</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Extradural abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Soft tissue infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cystitis bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Osteomyelitis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dermo-hypodermitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Post procedural sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Superinfection bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bone abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Infectious pleural effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pneumocystis jirovecii pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Infected seroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Medical device site infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Medical device site joint infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Perineal cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular device infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Complicated appendicitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Large intestine infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Brain herniation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Carbon monoxide poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Compression fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Failure to anastomose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="3256"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Fractured sacrum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Open fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Penetrating abdominal trauma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skull fractured base</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Traumatic ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular graft occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Traumatic fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Anastomotic stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Graft thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Wound complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Wound necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Coronary artery restenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Postoperative thoracic procedure complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Post laminectomy syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Underdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular procedure complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Post procedural bile leak</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Post procedural discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chemical burn of skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Post procedural oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular graft complication</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cerebral hyperperfusion syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastrointestinal anastomotic leak</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bone contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Periprosthetic fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral arterial reocclusion</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal column injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular graft thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pubis fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery restenosis</sub_title>
                <counts group_id="E1" events="22" subjects_affected="16" subjects_at_risk="3256"/>
                <counts group_id="E2" events="18" subjects_affected="15" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skin scar contracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Procedural intestinal perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular graft stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular graft restenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular access site haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arterial bypass thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arterial bypass occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arterial bypass stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Foreign body in gastrointestinal tract</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiovascular function test abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cystoscopy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Immunoglobulins decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Carbohydrate antigen 19-9 increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiac stress test abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular test</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ketoacidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lactic acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metabolic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic hyperosmolar nonketotic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypophagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Type 1 diabetes mellitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic metabolic decompensation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bone disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bone formation increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Fracture nonunion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Jaw cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metatarsalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Muscle disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="18" subjects_affected="14" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Tendon disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pseudarthrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spondyloarthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vertebral column mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Acquired claw toe</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ligament disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Soft tissue disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bone loss</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Soft tissue necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Systemic scleroderma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal stenosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Benign laryngeal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of skin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Benign ovarian tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bladder cancer stage IV</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bone cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Central nervous system lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cholangiocarcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cholesteatoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chronic myelomonocytic leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Follicular thyroid cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric cancer stage I</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric cancer stage II</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Laryngeal neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metastases to neck</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Neoplasm skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oropharyngeal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Papillary serous endometrial carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pleural mesothelioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rectal cancer stage I</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rectal cancer stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Small cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the oral cavity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the tongue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>T-cell lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Salivary gland adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metastases to peritoneum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Colorectal adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oesophageal cancer metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3256"/>
                <counts group_id="E2" events="16" subjects_affected="14" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Thymoma malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Respiratory tract neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lip and/or oral cavity cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Adrenal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oesophageal neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pancreatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rectal neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gingival cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Head and neck cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Inflammatory pseudotumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Adenolymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hepatocellular carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ductal adenocarcinoma of pancreas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Malignant genitourinary tract neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm papilla of Vater</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastrointestinal adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skin squamous cell carcinoma recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="3256"/>
                <counts group_id="E2" events="26" subjects_affected="24" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cerebral atrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Drop attacks</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Mental impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Parkinsonism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Status epilepticus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Tonic convulsion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vertebral artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Facial paresis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ischaemic neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Putamen haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cranial nerve disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pseudoradicular syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Colloid brain cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sacral radiculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device breakage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Device occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Patient-device incompatibility</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Device battery issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Acute psychosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Drug abuse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Organic brain syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Transient psychosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pelvi-ureteric obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ureteric fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>End stage renal disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cervical polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pelvic prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spermatocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vulvar dysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Prostatic obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vulval eczema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="23" subjects_affected="16" subjects_at_risk="3256"/>
                <counts group_id="E2" events="12" subjects_affected="9" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sinus polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vocal cord polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pharyngeal lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Tonsillar cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chronic respiratory disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Acute interstitial pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Haemorrhage subcutaneous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hidradenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pemphigoid</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pemphigus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skin exfoliation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Toxic skin eruption</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Drug reaction with eosinophilia and systemic symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ischaemic skin ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Myxoid cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Disease risk factor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Bladder calculus removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Blepharoplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Carotid endarterectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Foot amputation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Umbilical hernia repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vitrectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Radical prostatectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus management</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Transurethral bladder resection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral revascularisation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Brain tumour operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cystoprostatectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery angioplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Amputation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bladder polypectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Limb reconstructive surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery bypass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery stent insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Eventration repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="51" subjects_affected="43" subjects_at_risk="3256"/>
                <counts group_id="E2" events="58" subjects_affected="52" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral coldness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="44" subjects_affected="34" subjects_at_risk="3256"/>
                <counts group_id="E2" events="46" subjects_affected="29" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Poor peripheral circulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renovascular hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Temporal arteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lymphocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dry gangrene</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Subclavian artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lymphorrhoea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Iliac artery stenosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusion</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypertensive urgency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Venous occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Angiopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" events="14" subjects_affected="12" subjects_at_risk="3256"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="156" subjects_affected="125" subjects_at_risk="3256"/>
                <counts group_id="E2" events="182" subjects_affected="130" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ischaemic limb pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lymphatic fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" events="29" subjects_affected="25" subjects_at_risk="3256"/>
                <counts group_id="E2" events="17" subjects_affected="14" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.1</frequency_threshold>
        <default_vocab>MedDRA (22.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="725" subjects_at_risk="3256"/>
                <counts group_id="E2" subjects_affected="729" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="29" subjects_affected="29" subjects_at_risk="3256"/>
                <counts group_id="E2" events="23" subjects_affected="23" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="33" subjects_affected="31" subjects_at_risk="3256"/>
                <counts group_id="E2" events="49" subjects_affected="48" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="3256"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3256"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="17" subjects_affected="14" subjects_at_risk="3256"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="3256"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="24" subjects_affected="23" subjects_at_risk="3256"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="3256"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="3256"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3256"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3256"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="3256"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vascular stent stenosis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="3256"/>
                <counts group_id="E2" events="21" subjects_affected="17" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="3256"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="23" subjects_affected="21" subjects_at_risk="3256"/>
                <counts group_id="E2" events="32" subjects_affected="30" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="3256"/>
                <counts group_id="E2" events="27" subjects_affected="21" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery restenosis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Arterial bypass occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dyslipidaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="19" subjects_affected="18" subjects_at_risk="3256"/>
                <counts group_id="E2" events="37" subjects_affected="32" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="25" subjects_affected="23" subjects_at_risk="3256"/>
                <counts group_id="E2" events="33" subjects_affected="30" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="3256"/>
                <counts group_id="E2" events="16" subjects_affected="13" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="3256"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="58" subjects_affected="47" subjects_at_risk="3256"/>
                <counts group_id="E2" events="53" subjects_affected="52" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Spinal stenosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="27" subjects_affected="23" subjects_at_risk="3256"/>
                <counts group_id="E2" events="28" subjects_affected="26" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="3256"/>
                <counts group_id="E2" events="21" subjects_affected="19" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="3256"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="14" subjects_affected="9" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="3256"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="3256"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="3256"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Cataract operation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="3256"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="54" subjects_affected="49" subjects_at_risk="3256"/>
                <counts group_id="E2" events="56" subjects_affected="50" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="3256"/>
                <counts group_id="E2" events="15" subjects_affected="13" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3256"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="48" subjects_affected="39" subjects_at_risk="3256"/>
                <counts group_id="E2" events="48" subjects_affected="43" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3256"/>
                <counts group_id="E2" events="14" subjects_affected="11" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Dry gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3256"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusion</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="3256"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="45" subjects_affected="34" subjects_at_risk="3256"/>
                <counts group_id="E2" events="37" subjects_affected="31" subjects_at_risk="3248"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" events="16" subjects_affected="13" subjects_at_risk="3256"/>
                <counts group_id="E2" events="13" subjects_affected="10" subjects_at_risk="3248"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Therapeutic Area Head</name_or_title>
      <organization>Bayer</organization>
      <phone>(+)1-888-84 22937</phone>
      <email>clinical-trials-contact@bayer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

